A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults
Public ClinicalTrials.gov record NCT05333289. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1/2, Randomized, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1020 and mRNA-1030 Candidate Seasonal Influenza Vaccines in Healthy Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the safety, reactogenicity, and humoral immunogenicity of mRNA-1020, mRNA-1030, and mRNA-1010 vaccines against vaccine-matched influenza A and B strains.
Study identification
- NCT ID
- NCT05333289
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 572 participants
Conditions and interventions
Conditions
Interventions
- mRNA-1030 Biological
- mRNA-1020 Biological
- mRNA-1010 Biological
- Active Comparator Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 6, 2022 (Actual)
- Primary completion
- Nov 22, 2022 (Actual)
- Completion
- Nov 22, 2022 (Actual)
- Last update posted
- Feb 1, 2024
2022
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Foothills Research Center | Phoenix | Arizona | 85044 | — |
| Alliance for MultiSpecialty Research | Coral Gables | Florida | 33134 | — |
| Health Awareness, Inc. | Jupiter | Florida | 33458 | — |
| IACT Health | Columbus | Georgia | 31904 | — |
| Meridian Clinical Research | Sioux City | Iowa | 51106 | — |
| Heartland Research Associates, LLC | Wichita | Kansas | 67207 | — |
| Sundance Clinical Research, LLC | St Louis | Missouri | 63141 | — |
| Meridian Clinical Research | Endwell | New York | 13760 | — |
| Lucas Research | Morehead City | North Carolina | 28557 | — |
| Trial Management Associates, LLC | Wilmington | North Carolina | 28403 | — |
| Meridian Clinical Research | Cincinnati | Ohio | 45246 | — |
| Lynn Institute of Norman | Norman | Oklahoma | 73072 | — |
| LinQ Research, LLC | Pearland | Texas | 77584 | — |
| Olympus Family Medicine | Salt Lake City | Utah | 84117 | — |
| South Ogden Family Medicine | South Ogden | Utah | 84405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05333289, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 1, 2024 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05333289 live on ClinicalTrials.gov.